Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Bicara Therapeutics
Bicara Therapeutics
Revolution Medicines, Inc.
Carisma Therapeutics Inc
Advaxis, Inc.
Pfizer
Fate Therapeutics
Revolution Medicines, Inc.
The University of Texas Medical Branch, Galveston
Memorial Sloan Kettering Cancer Center